A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States
Since 2020, the US Preventive Services Taskforce has recommended expanding hepatitis C virus (HCV) screening to include ages 18−79, in addition to baby boomers (born 1945−1965) and those at-risk for hepatitis C virus. This retrospective cohort analysis compared patients (18 years and above) tested f...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-10-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/13/11/2140 |
| _version_ | 1797508203340103680 |
|---|---|
| author | Mary Cabell Jonas Kevin Rubenstein Eric Watson Sundeep Basra Michael Horberg |
| author_facet | Mary Cabell Jonas Kevin Rubenstein Eric Watson Sundeep Basra Michael Horberg |
| author_sort | Mary Cabell Jonas |
| collection | DOAJ |
| description | Since 2020, the US Preventive Services Taskforce has recommended expanding hepatitis C virus (HCV) screening to include ages 18−79, in addition to baby boomers (born 1945−1965) and those at-risk for hepatitis C virus. This retrospective cohort analysis compared patients (18 years and above) tested for HCV through usual care versus a coordinator-supported program (HCV pathway) during 2015−2018 within Kaiser Permanente Mid-Atlantic States (KPMAS). In total, 131,176 patients were tested through the HCV pathway and 128,311 through usual care (non-standardized testing). Of those tested, 1.6% (HCV pathway) and 0.5% (usual care) had chronic HCV. Of those with chronic HCV, more patients tested within the HCV pathway completed hepatic transient elastography (82.6% HCV pathway vs. 45.6% usual care; <i>p</i> < 0.001) and a gastroenterology visit (72.2% HCV pathway vs. 46.5% usual care; <i>p</i> < 0.001), and had filled prescriptions for treatment (56.5% HCV pathway vs. 40.3% usual care; <i>p</i> < 0.001). The median time to complete each step was shorter for those tested through the HCV pathway (hepatic transient elastography (26 vs. 118 days), gastroenterology visit (63 vs. 131 days), and prescription fill (222 vs. 326 days)). More patients tested through a coordinator-supported, standardized testing pathway completed the necessary testing steps, in less time, compared to usual care. These findings may inform institutions seeking to create effective population-wide testing programs for HCV and other conditions. |
| first_indexed | 2024-03-10T04:59:04Z |
| format | Article |
| id | doaj.art-51176b019c8e4a23abe61eab2f90dedf |
| institution | Directory Open Access Journal |
| issn | 1999-4915 |
| language | English |
| last_indexed | 2024-03-10T04:59:04Z |
| publishDate | 2021-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Viruses |
| spelling | doaj.art-51176b019c8e4a23abe61eab2f90dedf2023-11-23T01:55:30ZengMDPI AGViruses1999-49152021-10-011311214010.3390/v13112140A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic StatesMary Cabell Jonas0Kevin Rubenstein1Eric Watson2Sundeep Basra3Michael Horberg4Mid-Atlantic Permanente Research Institute, 2101 E. Jefferson Street, Rockville, MD 20852, USAMid-Atlantic Permanente Research Institute, 2101 E. Jefferson Street, Rockville, MD 20852, USAMid-Atlantic Permanente Research Institute, 2101 E. Jefferson Street, Rockville, MD 20852, USAMid-Atlantic Permanente Research Institute, 2101 E. Jefferson Street, Rockville, MD 20852, USAMid-Atlantic Permanente Research Institute, 2101 E. Jefferson Street, Rockville, MD 20852, USASince 2020, the US Preventive Services Taskforce has recommended expanding hepatitis C virus (HCV) screening to include ages 18−79, in addition to baby boomers (born 1945−1965) and those at-risk for hepatitis C virus. This retrospective cohort analysis compared patients (18 years and above) tested for HCV through usual care versus a coordinator-supported program (HCV pathway) during 2015−2018 within Kaiser Permanente Mid-Atlantic States (KPMAS). In total, 131,176 patients were tested through the HCV pathway and 128,311 through usual care (non-standardized testing). Of those tested, 1.6% (HCV pathway) and 0.5% (usual care) had chronic HCV. Of those with chronic HCV, more patients tested within the HCV pathway completed hepatic transient elastography (82.6% HCV pathway vs. 45.6% usual care; <i>p</i> < 0.001) and a gastroenterology visit (72.2% HCV pathway vs. 46.5% usual care; <i>p</i> < 0.001), and had filled prescriptions for treatment (56.5% HCV pathway vs. 40.3% usual care; <i>p</i> < 0.001). The median time to complete each step was shorter for those tested through the HCV pathway (hepatic transient elastography (26 vs. 118 days), gastroenterology visit (63 vs. 131 days), and prescription fill (222 vs. 326 days)). More patients tested through a coordinator-supported, standardized testing pathway completed the necessary testing steps, in less time, compared to usual care. These findings may inform institutions seeking to create effective population-wide testing programs for HCV and other conditions.https://www.mdpi.com/1999-4915/13/11/2140HCVscreeningusual-care testingnon-standardized testingKPMASHCV treatment |
| spellingShingle | Mary Cabell Jonas Kevin Rubenstein Eric Watson Sundeep Basra Michael Horberg A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States Viruses HCV screening usual-care testing non-standardized testing KPMAS HCV treatment |
| title | A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States |
| title_full | A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States |
| title_fullStr | A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States |
| title_full_unstemmed | A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States |
| title_short | A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States |
| title_sort | comprehensive coordinator supported hepatitis c virus testing and linkage to treatment program at kaiser permanente mid atlantic states |
| topic | HCV screening usual-care testing non-standardized testing KPMAS HCV treatment |
| url | https://www.mdpi.com/1999-4915/13/11/2140 |
| work_keys_str_mv | AT marycabelljonas acomprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT kevinrubenstein acomprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT ericwatson acomprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT sundeepbasra acomprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT michaelhorberg acomprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT marycabelljonas comprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT kevinrubenstein comprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT ericwatson comprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT sundeepbasra comprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT michaelhorberg comprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates |